Autopsy report · NCT03806985

Effects of Psilocybin in Concussion Headache

“Challenging to recruit qualifying subjects”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 4 years 3 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Yale University

Sponsor type

University, hospital or other

Conditions

Post-Traumatic Headache

Interventions

Placebo oral capsule; Low Dose Psilocybin; High Dose Psilocybin

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• Effect of Externally Implantable Tissue Expansion Device on Scar Length
  “Inability to recruit eligible subjects” (82% match in meaning)
• Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study
  “Difficulty recruiting subjects” (79% match in meaning)
• FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan
  “inability to recruit subjects” (77% match in meaning)
• Dermal Fillers Patient Satisfaction
  “Difficult to recruit subjects in the area.” (77% match in meaning)
• Insulin Resistance in Pulmonary Arterial Hypertension
  “difficulty in finding eligible subjects” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.